PharmaVOICE - The RWE Evolution
With so much attention being focused on real-world evidence (RWE) and real-world data (RWD), it would be easy to assume that this critical area of drug development is revolutionary. But, in fact, RWE has been around for decades and what the industry is currently experiencing is an evolution of processes founded in solid science and good clinical study practices to support regulatory, payer, and physician stakeholder decisions. That’s not to say there haven’t been some revolutionary forces at play to put patients at the heart of the RWE and RWD movement.